BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Serina Therapeutics Stock (SER) Soars 20% on FDA Support
Serina Therapeutics Stock (SER) Soars 20% on FDA Support
26
3
BTCCSquare news:
Serina Therapeutics (SER) shares surged 20% after the FDA endorsed its Parkinson's therapy candidate SER-252. The regulatory greenlight allows progression through the 505(b)(2) NDA pathway, potentially accelerating time-to-market for this twice-weekly injectable treatment.
CEO Steve Ledger emphasized a capital-efficient development strategy, aiming to generate robust clinical evidence while streamlining NDA submission. The therapy's POZ platform technology enables continuous dopaminergic stimulation, addressing motor fluctuations in advanced Parkinson's patients.
By:
